Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle

Launched by INSTITUTO UNIVERSITARIO DE INVESTIGACIONES BIOMÉDICAS Y SANITARIAS (IUIBS) DE LA UNIVERSIDAD DE LAS · Apr 6, 2025

Keywords

ClinConnect Summary

The clinical trial is studying the WARIFA app, which aims to help people adopt healthier lifestyles and manage conditions like Type 1 Diabetes (T1D) and other non-communicable diseases (NCDs). Through the app, participants will receive personalized recommendations based on their own health data, with the help of artificial intelligence. The goal is to see how effective the app is in promoting healthy behaviors and managing these conditions over a three-month period.

To participate, you need to be an adult over 18 years old and own a smartphone with internet access. There are two groups in this study: one for people with no more than one NCD (like heart disease, certain cancers, or Type 2 Diabetes) and another for those with Type 1 Diabetes who use insulin. Participants will be randomly assigned to either use the full WARIFA app with AI features or a version without AI. Throughout the study, participants will fill out questionnaires and undergo health checks at the beginning and end to track any changes. If you're interested, this trial is currently recruiting participants until May 2025, so there's still time to get involved!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Common for both population groups:
• • Adults over 18 years of age.
• • Owners of a smartphone operating with Android and with internet access.
• * Group 1: General population:
• • Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease).
• * Group 2: T1D:
• • Treatment with multiple subcutaneous insulin injections or an insulin pump.
• • Users of a continuous glucose monitor.
• Exclusion Criteria:
• * Common for both groups:
• • Pregnancy.
• • Mobile device which is incompatible with the WARIFA app (E.g. Apple devices).
• • Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian).
• • Any reason which precludes follow-up, based on the researcher's criteria.
• • Group 1: General population
• • People with two or more NCDs.